BC
HOWL icon

BIT Capital’s Werewolf Therapeutics HOWL Stock Holding History

BIT Capital’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-241,056
Closed -$357K – 129
2024
Q4 		$357K Hold
241,056
– – 0.03% 91
2024
Q3 		$511K Buy
241,056
+7,686
+3% +$17.5K 0.05% 86
2024
Q2 		$569K Buy
+233,370
New +$1.12M 0.04% 97

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT Capital's HOWL Position: Q1 2025 in Review

BIT Capital sold out of Werewolf Therapeutics (HOWL) in Q1 2025, closing a stake of 241,056 shares — an estimated $357K sold.

BIT Capital first reported a position in HOWL in Q2 2024 and held it in 3 quarters. The position peaked at $569K in Q2 2024. 70 funds tracked by Wall St. Rank hold HOWL as of Q1 2025.

  • BIT Capital reported no remaining Werewolf Therapeutics position as of Q1 2025 after selling out during the quarter.
  • BIT Capital sold 241,056 Werewolf Therapeutics shares in Q1 2025, an estimated $357K.
  • BIT Capital first reported a position in Werewolf Therapeutics in Q2 2024 and held it in 3 quarters.
  • BIT Capital's Werewolf Therapeutics position peaked at $569K in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.